rcs tirzepatide Microdose Retatrutide vs Tirzepatide: GLP-1, GIP

In late 2024, Saniona reported that Medix had not received approval and was in dialogue with the agency

Each is Janoshik tested with independently verifiable COAs

Ozempic is a GLP-1 receptor agonist that mimics the hormone glucagon-like peptide-1, slowing gastric emptying, reducing appetite, and improving insulin sensitivity

The entry of Pfizer into this segment highlights how therapeutic innovation and strategic market positioning go hand in hand

For patients interested in understanding their individual response to GLP-1 therapy, PlexusDx offers the Precision Peptide Genetic Testa peptide-pathway analysis that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights

Ozempic was originally developed for the treatment of diabetes, so those who have diabetes are eligible for Ozempic